Patents by Inventor David Michael Foreman

David Michael Foreman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Wound healing
    Publication number: 20100152095
    Abstract: A composition for use in the treatment of wounds to inhibit scar tissue formation during healing is disclosed, comprising an effective activity-inhibiting amount of a growth factor neutralising agent or agents specific against only fibrotic growth factors together with a pharmaceutically acceptable carrier. The method of preparation of said composition and method of administering the composition to a host suffering from tissue wounding is also disclosed.
    Type: Application
    Filed: June 8, 2009
    Publication date: June 17, 2010
    Applicant: RENOVO LIMITED
    Inventors: Mark William James Ferguson, David Michael Foreman, Mamta Shah
  • Wound healing
    Publication number: 20020187149
    Abstract: A composition for use in the treatment of wounds to inhibit scar tissue formation during healing is disclosed, comprising an effective activity-inhibiting amount of a growth factor neutralising agent or agents specific against only fibrotic growth factors together with a pharmaceutically acceptable carrier. The method of preparation of said composition and method of administering the composition to a host suffering from tissue wounding is also disclosed.
    Type: Application
    Filed: April 8, 2002
    Publication date: December 12, 2002
    Applicant: RENOVO LIMITED
    Inventors: Mark William James Ferguson, David Michael Foreman, Mamta Shah
  • Anti-scarring compositions comprising growth factor neutralizing antibodies
    Patent number: 5662904
    Abstract: A composition for use in the treatment of wounds to inhibit scar tissue formation during healing, comprising an effective amount of an activity-inhibiting growth factor neutralizing agent or agents specific against all TGF-.beta., except for TGF-.beta..sub.3, and PDGF, together with a pharmaceutically acceptable carrier. A method of preparing the composition and a method of administering the composition to a host suffering from tissue wounding is also disclosed.
    Type: Grant
    Filed: September 27, 1993
    Date of Patent: September 2, 1997
    Assignee: The Victoria University of Manchester
    Inventors: Mark William James Ferguson, David Michael Foreman, Mamta Shah